BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 32102602)

  • 1. Alcohol Use, Mental Health, and Functional Capacity as Predictors of Workplace Disability in a Cohort With Manifest Huntington's Disease.
    Goh AMY; You E; Perin S; Lautenschlager NT; Clay FJ; Loi SM; Chong T; Ames D; Chiu E; Ellis KA
    J Neuropsychiatry Clin Neurosci; 2020; 32(3):235-243. PubMed ID: 32102602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of Workplace Disability in a Premanifest Huntington's Disease Cohort.
    Goh AMY; You E; Perin S; Clay FJ; Loi S; Ellis K; Chong T; Ames D; Lautenschlager N
    J Neuropsychiatry Clin Neurosci; 2018; 30(2):115-121. PubMed ID: 29183234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of Working Capacity Changes Related to Huntington's Disease: A Longitudinal Study.
    van der Zwaan KF; Jacobs M; van Zwet EW; Roos RAC; de Bot ST
    J Huntingtons Dis; 2021; 10(2):269-276. PubMed ID: 33523014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of manifest Huntington's disease with clinical and imaging measures: a prospective observational study.
    Paulsen JS; Long JD; Ross CA; Harrington DL; Erwin CJ; Williams JK; Westervelt HJ; Johnson HJ; Aylward EH; Zhang Y; Bockholt HJ; Barker RA;
    Lancet Neurol; 2014 Dec; 13(12):1193-201. PubMed ID: 25453459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic and Environmental Contributors to Neurodegeneration: An Exploration of the Effects of Alcohol on Clinical Features of Huntington's Disease Using the Enroll-HD Global Platform.
    Symonds AL; Macerollo A; Foy K; Alusi SH; Davies R
    Int J Environ Res Public Health; 2021 May; 18(10):. PubMed ID: 34065918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring the predictors of financial impairment in Huntington's disease using the Enroll-HD dataset.
    Harris KL; Mason SL; Barker RA
    J Neurol; 2022 Jul; 269(7):3501-3510. PubMed ID: 35165768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mild cognitive impairment and dementia in motor manifest Huntington's disease: Classification and prevalence.
    Julayanont P; McFarland NR; Heilman KM
    J Neurol Sci; 2020 Jan; 408():116523. PubMed ID: 31678902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determinants of functional disability in Huntington's disease: role of cognitive and motor dysfunction.
    Ross CA; Pantelyat A; Kogan J; Brandt J
    Mov Disord; 2014 Sep; 29(11):1351-8. PubMed ID: 25216368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing Mental Health Difficulties of Persons With Huntington's Disease: Does Informant Presence Make a Difference?
    Gunn S; Maltby J; Dale M
    J Neuropsychiatry Clin Neurosci; 2020; 32(3):244-251. PubMed ID: 32102601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Timing and Impact of Psychiatric, Cognitive, and Motor Abnormalities in Huntington Disease.
    McAllister B; Gusella JF; Landwehrmeyer GB; Lee JM; MacDonald ME; Orth M; Rosser AE; Williams NM; Holmans P; Jones L; Massey TH;
    Neurology; 2021 May; 96(19):e2395-e2406. PubMed ID: 33766994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impacts of heavy smoking and alcohol consumption on workplace presenteeism: A cross-sectional study.
    Lee SY; Lee J; Kwon M
    Medicine (Baltimore); 2021 Nov; 100(47):e27751. PubMed ID: 34964731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biological and clinical manifestations of juvenile Huntington's disease: a retrospective analysis.
    Fusilli C; Migliore S; Mazza T; Consoli F; De Luca A; Barbagallo G; Ciammola A; Gatto EM; Cesarini M; Etcheverry JL; Parisi V; Al-Oraimi M; Al-Harrasi S; Al-Salmi Q; Marano M; Vonsattel JG; Sabatini U; Landwehrmeyer GB; Squitieri F
    Lancet Neurol; 2018 Nov; 17(11):986-993. PubMed ID: 30243861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Understanding HD Psychosis: An Analysis from the ENROLL-HD Database.
    Jaini A; Yomtoob J; Yeh C; Bega D
    Tremor Other Hyperkinet Mov (N Y); 2020 Jul; 10():16. PubMed ID: 32775030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Employment and absenteeism in working-age persons with multiple sclerosis.
    Salter A; Thomas N; Tyry T; Cutter G; Marrie RA
    J Med Econ; 2017 May; 20(5):493-502. PubMed ID: 28035846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severity of cognitive impairment in juvenile and late-onset Huntington disease.
    Gómez-Tortosa E; del Barrio A; García Ruiz PJ; Pernaute RS; Benítez J; Barroso A; Jiménez FJ; García Yébenes J
    Arch Neurol; 1998 Jun; 55(6):835-43. PubMed ID: 9626775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparing the effects on work performance of mental and physical disorders.
    de Graaf R; Tuithof M; van Dorsselaer S; ten Have M
    Soc Psychiatry Psychiatr Epidemiol; 2012 Nov; 47(11):1873-83. PubMed ID: 22434047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suicidal ideation in Huntington disease: the role of comorbidity.
    Wetzel HH; Gehl CR; Dellefave-Castillo L; Schiffman JF; Shannon KM; Paulsen JS;
    Psychiatry Res; 2011 Aug; 188(3):372-6. PubMed ID: 21605914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Huntington's Disease and Employment: The Relative Contributions of Cognitive and Motor Decline to the Decision to Leave Work.
    Watkins K; Purks J; Kumar A; Sokas RK; Heller H; Anderson KE
    J Huntingtons Dis; 2018; 7(4):367-377. PubMed ID: 30198875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sleep disturbances by disease type and stage in Huntington's disease.
    Ogilvie AC; Nopoulos PC; Schultz JL
    Parkinsonism Relat Disord; 2021 Oct; 91():13-18. PubMed ID: 34450461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age of onset and behavioral manifestations in Huntington's disease: An Enroll-HD cohort analysis.
    Ranganathan M; Kostyk SK; Allain DC; Race JA; Daley AM
    Clin Genet; 2021 Jan; 99(1):133-142. PubMed ID: 33020896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.